Interactive panel discussed the evolving area of data transfer and the usage of EHR-to-EDC.
In an interactive panel at SCOPE Europe 2023 in Barcelona, Spain, participants discussed the concept of eSource data captured in EHRs transforming the way clinical trials are being run. A video of the discussion can be found below.
Moderated by Mats Sundgren, PhD, senior industry scientific director, i-HD (European Institute for Innovation through Health Data), the panel members included Peter Casteleyn, director, clinical data collection solutions-EHR, The Janssen Pharmaceutical Companies of Johnson and Johnson, Paul Jacobs, associate director, development innovation, Regeneron Pharmaceuticals, and Joe Lengfellner, senior director, clinical research informatics, Memorial Sloan Kettering Cancer Center.
The first question posed to the panel from Sundgren was around the challenges and opportunities each are facing in the area of data transfer. The participants highlighted data collection and quality as challenges. Specifically, the amount of data and the increasing workload it is creating for operational staff. However, there are opportunities to streamline these processes with new and improved technology.
The panel also focused on value-generation, which tied the conversation back to the earlier point on increasing workload. Organizations are trying to pinpoint the cost of queries and patient/site monitoring and how much time they are spending on them. What is the breakeven point for expending resources on these new technologies in order to achieve improved data transfer?
To conclude, the panel spoke on what the future could look like in this space. The panelists were in agreement that interoperability and adoption are trends stakeholders should be keeping top of mind in the next few years.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.